Lung-MAP: Master Protocol for Lung Cancer
The Lung Cancer Master Protocol, or Lung-MAP, is a precision medicine research study for people with advanced non-small cell lung cancer that has continued to grow after treatment. Patients are assigned to different study drug combinations based on the results of genomic profiling of their tumors.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/789639/syndication
- Syndication ID: 3569
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Saturday, August 29, 2015 at 01:00 AM
- Date Syndication Updated: Monday, August 05, 2019 at 07:43 PM
Tags
General:
lung
squamous
protocol
nctn
lung-map
non-small cell
Embed Code Snippet
To get the embed code snippet please Login.
